Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11526
CALL
Coherus Oncology
CHRS
$226M
| $66.3K | ﹤0.01% |
19,900
-95,800
| -83% | -$257K |
|
11527
PUT
Globus Maritime Ltd
GLBS
$77.9M
| $66.3K | ﹤0.01% |
25,000
+11,600
| +87% | +$24.8K |
|
11528
FerroAtlántica
GSM
$757M
| $66.2K | ﹤0.01% |
10,175
-887
| -8% | -$4.69K |
|
|
FGH
11529
CALL
DELISTED
FG Group Holdings Inc.
FGH
| $66.2K | ﹤0.01% |
45,000
-4,900
| -10% | -$6.99K |
|
11530
Information Services Group
III
$244M
| $66.1K | ﹤0.01% |
14,027
+3,539
| +34% | +$15.5K |
|
|
FFAI
11531
Faraday Future Intelligent Electric
FFAI
$8.98M
| $66.1K | ﹤0.01% |
+16
| New | +$214K |
|
11532
Flotek Industries
FTK
$884M
| $66K | ﹤0.01% |
+16,846
| New | +$65.5K |
|
|
HERZ
11533
Herzfeld Credit Income Fund
HERZ
$32M
| $66K | ﹤0.01% |
2,653
+402
| +18% | +$9.55K |
|
11534
CALL
AudioEye
AEYE
$90.4M
| $65.6K | ﹤0.01% |
+12,100
| New | +$54.9K |
|
11535
DHI Group
DHX
$178M
| $65.5K | ﹤0.01% |
+25,287
| New | +$65.1K |
|
11536
PUT
X4 Pharmaceuticals
XFOR
$419M
| $65.4K | ﹤0.01% |
2,593
+1,993
| +332% | +$48.5K |
|
11537
Ampco-Pittsburgh
AP
$190M
| $65.1K | ﹤0.01% |
23,836
+6,970
| +41% | +$18.7K |
|
11538
PUT
Heron Therapeutics
HRTX
$63M
| $64.9K | ﹤0.01% |
+38,200
| New | +$42.1K |
|
11539
CALL
Champions Oncology
CSBR
$69.7M
| $64.9K | ﹤0.01% |
12,000
-1,400
| -10% | -$7.81K |
|
11540
Nautilus Biotechnolgy
NAUT
$115M
| $64.9K | ﹤0.01% |
+21,710
| New | +$62.1K |
|
11541
Adicet Bio
ACET
$84.3M
| $64.9K | ﹤0.01% |
2,147
+1,366
| +175% | +$29.8K |
|
|
FCO
11542
DELISTED
abrdn Global Income Fund
FCO
| $64.8K | ﹤0.01% |
10,029
-8,774
| -47% | -$53.5K |
|
|
SGMA
11543
DELISTED
Sigmatron International
SGMA
| $64.7K | ﹤0.01% |
+21,564
| New | +$67.7K |
|
11544
PMV Pharmaceuticals
PMVP
$66.3M
| $64.6K | ﹤0.01% |
20,854
-129,253
| -86% | -$342K |
|
11545
Brilliant Earth
BRLT
$22.1M
| $64.6K | ﹤0.01% |
17,357
+56
| +0.3% | +$161 |
|
11546
Blue Ridge Bankshares
BRBS
$350M
| $64.5K | ﹤0.01% |
+21,282
| New | +$65.1K |
|
11547
CALL
NuScale Power
SMR
$4B
| $64.2K | ﹤0.01% |
19,500
+1,600
| +9% | +$5.69K |
|
11548
CALL
Toro Corp
TORO
$215M
| $64K | ﹤0.01% |
+13,000
| New | +$58.6K |
|
11549
PUT
Bionano Genomics
BNGO
$14.3M
| $63.9K | ﹤0.01% |
563
-1,082
| -66% | -$113K |
|
|
AWIN
11550
DELISTED
AERWINS Technologies Inc
AWIN
| $63.7K | ﹤0.01% |
+4,211
| New | +$57.8K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.